VPS9D1 and neoplasm: Our models successfully demonstrated that primed CD8+ T cells from OT-1 mice suppressed the proliferation of MC38-CTRL-OVA and MC38-VPS9D1 OE-OVA tumor cells (Figure 5F, Figure 5—figure supplement 1C).